ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Generic Drug User Fees Funding for FDA, including, but not limited to any proposal relating to funding for the Office of Generic Drugs FY2010 Presidential Budget Request FY2010 Congressional Budget and Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | Democratic Chief Floor Counsel |
| JASON R MONEY | — |
Trade (domestic/foreign) TRD
Free Trade Agrements, including but not limited to the Trans-Pacific Partnership FTA Any matters related to international activities with regard to access to generic medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | Democratic Chief Floor Counsel |
| JASON R MONEY | — |
Copyright/Patent/Trademark CPT
Patent Reform, including, but not limited to: S.515, S.610, and H.R.1260 Patent Settlements/Reverse Payments/Exclusionary Payments, including, but not limited to: S.369 and H.R.1706 Legislation relating to patent term extensions Any other matter that relates to access to generic drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | Democratic Chief Floor Counsel |
| JASON R MONEY | — |
Medicare/Medicaid MMM
Medicaid Reimbursement Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs Average Manufacture Price (AMP)/AMP Publication Medicare Part D Drug Program, expanding rebates to Part D program
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | Democratic Chief Floor Counsel |
| JASON R MONEY | — |
Pharmacy PHA
Generic Biologics, including but not limited to: H.R.1427, H.R.1548, and S.726 Prescription Drug Safety Counterfeit Drugs/Import Safety/Pedigree, such as: H.R.759 Authorized Generics, including, but not limited to: S.501 and H.R.573 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN D JAEGER | — |
| CHARLES L KINNEY | Democratic Chief Floor Counsel |
| JASON R MONEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.